Yahoo! Finance Search - Finance Home - Yahoo! - Help
EDGAR Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
PGNX > SEC Filings for PGNX > Form 8-K on 26-Jan-2009All Recent SEC Filings

Show all filings for PROGENICS PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for PROGENICS PHARMACEUTICALS INC

26-Jan-2009

Other Events


Item 8.01. Other Events.

Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), with which Progenics collaborates in the development and commercialization of RELISTOR®, has informed Progenics that global net sales of RELISTOR for the fourth quarter of 2008 were $1.5 million, as compared to $0.8 million in the third quarter of 2008. Wyeth began full promotion of RELISTOR in mid-August, under a program that included sales detailing, the offering of early experience trial kits and company-directed educational programs. Global net sales for 2008, which commenced in June, totaled $4.4 million.

RELISTOR is the first drug in a novel class for a completely new therapeutic use
- opioid-induced constipation. The approved indication for RELISTOR addresses the needs of individuals with advanced illness receiving palliative care. Ongoing clinical studies have the goal of expanding the use of RELISTOR in other patient settings.

  Add PGNX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PGNX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.